Dr. Streby is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
700 Childrens Dr
Columbus, OH 43205Phone+1 614-722-3552Fax+1 614-722-3699
Summary
- Dr. Keri Streby is a pediatric hematologist/oncologist in Columbus, OH and is affiliated with Nationwide Children's Hospital. She received her medical degree from Northeast Ohio Medical University and has been in practice 9 years. She is experienced in neuroblastoma, oncolytic virotherapy, and translational research.
Education & Training
Nationwide Children's Hospital/Ohio State UniversityFellowship, Pediatric Hematology/Oncology, 2011 - 2014- Nationwide Children's Hospital/Ohio State UniversityResidency, Pediatrics, 2008 - 2011
Northeast Ohio Medical UniversityClass of 2008
Certifications & Licensure
OH State Medical License 2008 - 2026- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- Early Career Award American Society of Pediatric Hematology/Oncology, 2015
- House staff officer of the year Nationwide Children's Hospital, 2011
- House staff of the year Nationwide Children's Hospital, 2010
Clinical Trials
- Combination Therapy of Antibody Hu3F8 With Granulocyte- Macrophage Colony Stimulating Factor (GM-CSF) in Patients With Relapsed/Refractory High-Risk Neuroblastoma Start of enrollment: 2012 Dec 01
- Immunotherapy of Relapsed Refractory Neuroblastoma With Expanded NK Cells Start of enrollment: 2019 Jan 14
- Neuroblastoma Maintenance Therapy Trial Start of enrollment: 2016 Feb 01
- Join now to see all
Publications & Presentations
PubMed
- 40 citationsFirst-in-Human Intravenous Seprehvir in Young Cancer Patients: A Phase 1 Clinical Trial.Keri A. Streby, Mark A. Currier, Melinda Triplet, Kristy Ott, Devon J. Dishman
Molecular Therapy. 2019-11-06 - 29 citationsVEGF Blockade Enables Oncolytic Cancer Virotherapy in Part by Modulating Intratumoral Myeloid CellsMark A. Currier, Francis Eshun, Allyson Sholl, Artur Chernoguz, Kelly M. Crawford
Molecular Therapy. 2013-05-01 - 12 citationsProgression-Free Survival and Patterns of Response in Patients With Relapsed High-Risk Neuroblastoma Treated With Irinotecan/Temozolomide/Dinutuximab/Granulocyte-Macro...Benjamin J Lerman, Yimei Li, Cecilia Carlowicz, Meaghan Granger, Thomas Cash
Journal of Clinical Oncology. 2023-01-20
Professional Memberships
- Advances in Neuroblastoma Research AssociationMember
- Childrens Oncology GroupMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
